Friday, November 20, 2015 10:21:19 PM
Your main concern appears to be that MSTX is not attempting to cure Sickle Cell Disease, right? (Just trying to sort this out.) and you are talking about a test. Would that be a test to rule out the chance that a baby in utero has the genes for sickle cell disease? I understand you may be talking about amniocentesis and somehow are connecting an eventual cure to sickle cell disease. I do not see anything wrong with a desire for those and maybe there is a company or a university that is working on certain aspects of those genetic studies and and the application of that to an eventual cure. You might want to google those and you may find satisfaction in supporting those researchers who are developing a platform , moving more toward your desires.
I am much impressed with the MSTX platform and stated goals. I am impressed with the continuity and focus of research programming. It appears to me that their accomplishments well support the reduction of human suffering. (There will be a time when family members are able to share their personal experiences with this drugs function in the SICKLE CELL vascular occlusive event. ) Its a drug platform addressing vascular and blood health, specific to the traumatic occlusive event. It is not a genetic platform or a cure platform. But once again, there may be researchers who's body of work more closely matches your desires. There would be nothing wrong with your presenting your desires with the MSTX board. It is important that you, as an active investor, express your desires, directly. There is no one here who can address your concerns, whether they agree with you or not, right? I wish you all the best. I appreciate that there is nothing I can do to assist you. But good luck in your endeavor. All stated here is strictly my opinion.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM